BioGaia starts its own distribution in Canada
Starting in 2023, BioGaia will be selling probiotics under its own management in Canada. Following the acquisition of Nutraceutics in...
Read moreBioGaia® Osfortis® winner of the NutraIngredients Awards 2022
We are proud to announce that our probiotic for bone health, Osfortis, is the winner of the 2022 NutraIngredients Awards...
Read moreRecord date for share split in BioGaia AB (publ) determined as 19 May 2022
At BioGaia’s Annual General Meeting held earlier today, on 6 May 2022, it was resolved on a share split...
Read moreAnnual General Meeting of BioGaia
The Annual General Meeting of BioGaia AB (publ) on 6 May 2022 voted, among other things, to approve the following...
Read moreBioGaia AB Interim Management Statement – January – March 2022
FIRST QUARTER 2022 Net sales amounted to SEK 283.9 million (202.0), an increase of SEK 81.9 million,...
Read moreBioGaia® Osfortis® winner of the NutraIngredients Awards 2022
We are proud to announce that our probiotic for bone health, Osfortis, is the winner of the 2022 NutraIngredients Awards...
Read moreNotice to attend the Annual General Meeting of BioGaia AB (publ)
BioGaia AB (publ) will hold its Annual General Meeting on Friday, 6 May 2022. The meeting will be held through...
Read moreBioGaia publishes annual report for 2021
Today, BioGaia AB (publ) publishes its Annual Report, Remuneration Report and Sustainability Report for the financial year 2021. In line...
Read more